Clinical Trials
Page 4 • 12 itemsAccess global clinical trial data, regulatory updates, and competitive intelligence for strategic pharma R&D and investment decisions.
RNA Therapy Clinical Trials Market Reaches $3.4 Billion as Personalized Medicine Drives Growth Through 2035
RNA therapy clinical trials market hits $3.4B driven by delivery advances, rare disease funding, and personalized medicine growth through 2035.
CLINUVEL Receives EMA Approval for SCENESSE Phase III Vitiligo Trial Starting 2026
CLINUVEL gets final EMA scientific advice for pivotal Phase III vitiligo study comparing SCENESSE with NB-UVB therapy, set to begin second half 2026.
RenovoRx TAMP Therapy Platform Data Accepted for 2026 ASCO Presentation - Phase III TIGeR-PaC Trial Results
RenovoRx announces ASCO acceptance of pharmacokinetic data from Phase III TIGeR-PaC trial testing TAMP therapy platform for pancreatic cancer treatment.
Clinical Trial Data Sharing in Europe: EMA's New Open Science Mandate
The EMA's new Open Science mandate aims to improve clinical trial data sharing across Europe, fostering transparency and collaboration in drug development.
Phase 1 Trial Evolution: EMA’s New Safety Monitoring Requirements Explained
This article delves into the EMA's updated safety monitoring requirements for Phase 1 trials, focusing on DrugX's role in cancer treatment and patient safety.
Center for Cancer and Blood Disorders Launches CAR T-Cell Therapy Program in Maryland, Expanding Community Access
CCBD becomes first Maryland community oncology practice to offer FDA-approved CAR T-cell therapy, significantly expanding patient access in the region.
Repertoire Immune Medicines Doses First Patient in RPTR-1-201 Phase 1/2 Trial for Advanced Solid Tumors
Repertoire Immune Medicines begins Phase 1/2 trial of RPTR-1-201, a novel TCR bispecific therapy targeting advanced solid tumors across US and European sites.
Alpha Tau Treats First Patient with Alpha DaRT in European Pancreatic Cancer Trial ACAPELLA
Alpha Tau initiates Alpha DaRT treatment in ACAPELLA trial for locally advanced pancreatic cancer, addressing unmet need for 42,000 European patients annually.
Alpha Tau Treats First European Pancreatic Cancer Patient with Alpha DaRT in ACAPELLA Clinical Trial
Alpha Tau successfully treats first European patient with Alpha DaRT radiotherapy in French ACAPELLA trial for locally advanced pancreatic cancer.
Blinatumomab Long-Term Safety Study in Pediatric Leukemia Patients Reaches Final Stage
European study evaluating long-term safety of blinatumomab versus chemotherapy in pediatric acute lymphoblastic leukemia patients nears completion.
Belite Bio Submits New Drug Application for Tinlarebant to Treat Stargardt Disease Following Positive Phase 3 Results
Belite Bio initiates rolling NDA submission for tinlarebant after Phase 3 DRAGON trial showed 35.7% reduction in retinal lesion growth for Stargardt disease patients.
Abivax Presents Obefazimod Phase 3 Data at Digestive Disease Week 2026
Abivax showcases comprehensive Phase 3 ABTECT program results for obefazimod in inflammatory bowel disease at DDW 2026 conference.